Added to YB: 2022-10-19
Pitch date: 2022-10-19
AKUS [bullish]
Akouos, Inc.
+0.3%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Akouos, Inc. develops gene therapies to restore, improve, and preserve physiologic hearing for individuals.
Market Cap
$491.0M
Pitch Price
$13.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.19
P/E
-5.09
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
AKOUOS INC AKUS
A summary for this pitch has not been created yet.
Read full article (0 min)